Healthcare

HHS searches for treatment for mustard gas

By Robert King
Published September 24, 2018 5:40pm ET
Add Washington Examiner on Google
HHS searches for treatment for mustard gas
A marine officer of the Cape Ray, a ship equipped to neutralize Syrian chemicals, shows a chemical protection suit to reporters, during a tour around the ship docked at the naval base of Rota used by the U.S, in Spain’s southwestern coast on Thursday, April 10, 2014. The American ship MV Cape Ray will collect and destroy mustard gas, raw materials for sarin nerve gas and tons of other highly toxic chemicals that form part of Syria’s chemical weapons program. If Syria can remove all its ingredients for making poison gas and nerve agent from the country by the end of the month, an ambitious June 30 deadline for destroying the chemicals should be met, a spokesman for the world's chemical weapons watchdog said Thursday. | (AP Photo/Alfonso Perez)

The Trump administration has partnered with the pharmaceutical company MediWound to develop a treatment for injuries caused by mustard gas, which was first used in World War I but officials worry could be used by terrorists.

The Department of Health and Human Services announced the $43 million partnership with the Israeli company to develop a skin treatment for injuries on Monday. Currently, there are no treatments available for mustard gas approved by the Food and Drug Administration.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Chemical Weapons Department of Health and Human Services ISIS